Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
10%
ALSO IN MEDX
MEDX
27
HOLDINGS
41%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.5% | 18.0% | 10.5% |
|
JOHNSON & JOHNSON | 6.1% | 4.9% | 4.9% |
|
ABBVIE INC | 4.8% | 8.5% | 4.8% |
|
MERCK & CO. INC. | 3.4% | 3.7% | 3.4% |
|
AMGEN INC | 2.2% | 3.9% | 2.2% |
IXJ Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 3.9% |
 |
ROCHE HOLDING LTD | 3.7% |
 |
ASTRAZENECA PLC | 3.6% |
|
NOVARTIS AG | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
ABBOTT LABORATORIES | 2.7% |
|
INTUITIVE SURGICAL INC | 2.6% |
 |
NOVO NORDISK A/S-B | 2.3% |
|
DANAHER CORP | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
IXJ Underweight Relative to MEDX
|
ELI LILLY & CO | -7.5% |
|
NOVARTIS AG-ADR | -6.8% |
|
ASTRAZENECA PLC-SPONS ADR | -5.5% |
|
IONIS PHARMACEUTICALS, INC. | -5.0% |
|
ALNYLAM PHARMACEUTICALS INC | -5.0% |
|
ABBVIE INC | -3.7% |
 |
ALKERMES PLC | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.3% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.9% |